IsoRay, Inc. (NYSE MKT:ISR) IsoRay is a clinical stage biopharmaceutical company with a strong focus on treatment of cancer who’s stock is …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the on-line publication of the …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced that a number of industry leaders …
IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced the start of a new study …
IsoRay, Inc.(NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced it will host a booth at the …
IsoRay Inc. (NYSE MKT: ISR) (www.
Maxim Group analyst Jason Kolbert came out today with an update on IsoRay, Inc. (NYSE MKT:ISR), after the company released it’s fiscal second-quarter results this morning.
Maxim’s healthcare analyst Jason Kolbert weighed in today with his thoughts on IsoRay Inc (NYSE:ISR), as the company announced that researchers at the University of Pittsburgh School …
Cesium-131 Seed Brachytherapy Offers Extremely High Efficacy Compared to Other Isotopes or Treatment Modalities Used in Treating Prostate Cancer, with the Advantage of …